Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | HCAR3 | P49019 | 2/20 | 0.34 |
| ▸ | RRM2 | P31350 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3375185 | 0.76 | RRM2 (0.38) | CA12CA1CA2CA9CA14 | |
| SCHEMBL5549248 | 0.74 | RRM2 (0.38) | CA12CA1CA2CA9CA14 | |
| SCHEMBL9812130 | 0.72 | ALDH1A1 (0.37) | CA12CA1CA2CA9CA14 | |
| SCHEMBL476574 | 0.71 | MAPT (0.42) | CA12CA1CA2CA9CA14 | |
| SCHEMBL11769725 | 0.69 | CA12 (0.35) | CA12CA1CA2CA9 | |
| SCHEMBL12502010 | 0.68 | HCAR3 (0.35) | CA12CA1CA2CA9CA14 | |
| SCHEMBL16831152 | 0.67 | CA12 (0.37) | CA12CA1CA2CA9CA14 | |
| SCHEMBL9220813 | 0.67 | ALDH1A1 (0.44) | CA12CA1CA2CA9CA14 | |
| SCHEMBL4784858 | 0.66 | ALDH1A1 (0.44) | CA12CA1CA2CA9CA14 | |
| SCHEMBL15823268 | 0.66 | ALDH1A1 (0.50) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9943809-B2 | Solvent resistant thin film composite membrane and its preparation | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2018-04-17 | — | — | US | claimed |
| US-20170065937-A1 | SOLVENT RESISTANT THIN FILM COMPOSITE MEMBRANE AND ITS PREPARATION | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2017-03-09 | — | — | US | claimed |
| US-5693227-A | POLYMERIZATION OF MOLECULES HAVING ELECTROPHILIC AND NUCLEOPHILIC SUBSTITUENTS ON THE SAME OR DIFFERENT MOLECULES; REGENERATION OF AMINOPYRIDINE CATALYSTS | IONICS, INCORPORATED (US) | 1997-12-02 | — | — | US | claimed |
| US-12036515-B2 | Thin-film composite membrane and methods of making and using the same | THE PENN STATE RESEARCH FOUNDATION (PA) | 2024-07-16 | — | — | US | disclosed |
| US-20210370240-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | THE PENN STATE RESEARCH FOUNDATION | 2021-12-02 | — | — | US | disclosed |
| EP-3860743-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | The Penn State Research Foundation (US) | 2021-08-11 | — | — | EP | disclosed |
| WO-2020072594-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | THE PENN STATE RESEARCH FOUNDATION (US) | 2020-04-09 | — | — | WO | disclosed |
| US-9943809-B2 | Solvent resistant thin film composite membrane and its preparation | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2018-04-17 | — | — | US | disclosed |
| US-20170065937-A1 | SOLVENT RESISTANT THIN FILM COMPOSITE MEMBRANE AND ITS PREPARATION | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2017-03-09 | — | — | US | disclosed |
| US-7727434-B2 | Membranes and methods of treating membranes | GENERAL ELECTRIC COMPANY (US) | 2010-06-01 | — | — | US | disclosed |
| US-20070039874-A1 | Membranes and methods of treating membranes | GENERAL ELECTRIC COMPANY | 2007-02-22 | — | — | US | disclosed |
| US-5693227-A | POLYMERIZATION OF MOLECULES HAVING ELECTROPHILIC AND NUCLEOPHILIC SUBSTITUENTS ON THE SAME OR DIFFERENT MOLECULES; REGENERATION OF AMINOPYRIDINE CATALYSTS | IONICS, INCORPORATED (US) | 1997-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12036515-B2 | Thin-film composite membrane and methods of making and using the same | PORCN, MLEC, FLOT1 | CA12 1547/4885CA1 2322/4885CA2 3089/4885 |
| US-20210370240-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | PORCN, MLEC, FLOT1 | CA12 1547/4885CA1 2322/4885CA2 3089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.